This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...
Myeloma NZ
Severe Renal Impairment Worsens Outcomes in Multiple Myeloma
This was originally published by AJMC Severe renal impairment (RI) is associated with decreased rates of survival among patients with multiple...
Inpatient Mortality With Renal Impairment in Patients With Multiple Myeloma
This article was originally published by Cancer Therapy Advisor Receipt of dialysis may be a risk factor for inpatient mortality in patients with...
EU Approval Urged for GSX’s Belantamab Mafodotin for Heavily Treated Myeloma
This post was originally published by Myeloma Research News GlaxoSmithKline’s investigational therapy belantamab mafodotin has been...
FDA Office Favors Antibody-drug Conjugate for Advanced Multiple Myeloma
An office of the U.S. Food and Drug Administration (FDA has recommended that belantamab mafodotin, GlaxoSmithKline’s investigational...
Upcoming Patient Seminar: Whangarei Myeloma Seminar
Come along to our Whangarei Myeloma Patient Seminar, hosted by Myeloma New Zealand and Leukaemia & Blood cancer New Zealand. During the evening,...
Case Report Describes Late-onset MG in Man Treated for Multiple Myeloma
This post was originally published by Myasthenia Gravis News A 60-year-old man being treated for multiple myeloma was found to...
Cho Provides Background on the Multiple Myeloma Research Foundation’s CureCloud Study
This story was originally published by Targeted Oncology Hearn Jay Cho, MD, PhD, chief medical officer, Multiple Myeloma Research Foundation (MMRF),...
Gut Microbiome Could Play Key Role in Multiple Myeloma
This was originally published by AJMC The bone marrow (BM) microenvironment is believed to play a key role in the evolution of monoclonal gammopathy...
HealthTree® Launches HealthTree University for Multiple Myeloma Patients
This was originally posted by Cision PR Newswire SALT LAKE CITY, July 9, 2020 /PRNewswire/ -- HealthTree®, the first online portal...
FDA Places MELANI-01 Study for Multiple Myeloma on Hold After Safety Report Submission
This article was originally published by Cancer Network Cellectis recently announced the FDA placed its MELANI-01 trial treating multiple myeloma on...
Patients with Multiple Myeloma and CHIP Face Worse Outcomes Following ASCT
However, when followed by immunomodulatory drugs, researchers found that autologous stem cell transplant can be safely used in this patient...